rs111033503

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_000260.4(MYO7A):​c.736-15_736-4dupTGCCCACATTTT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00366 in 1,591,982 control chromosomes in the GnomAD database, including 137 homozygotes. It is difficult to determine the true allele frequency of this variant because it is of type INS_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.018 ( 79 hom., cov: 33)
Exomes 𝑓: 0.0022 ( 58 hom. )

Consequence

MYO7A
NM_000260.4 splice_region, intron

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 1.25

Publications

1 publications found
Variant links:
Genes affected
MYO7A (HGNC:7606): (myosin VIIA) This gene is a member of the myosin gene family. Myosins are mechanochemical proteins characterized by the presence of a motor domain, an actin-binding domain, a neck domain that interacts with other proteins, and a tail domain that serves as an anchor. This gene encodes an unconventional myosin with a very short tail. Defects in this gene are associated with the mouse shaker-1 phenotype and the human Usher syndrome 1B which are characterized by deafness, reduced vestibular function, and (in human) retinal degeneration. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2008]
MYO7A Gene-Disease associations (from GenCC):
  • nonsyndromic genetic hearing loss
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal recessive nonsyndromic hearing loss 2
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics, G2P
  • Usher syndrome type 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, PanelApp Australia
  • Usher syndrome type 1B
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • autosomal dominant nonsyndromic hearing loss 11
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Usher syndrome type 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 11-77157263-G-GTGCCCACATTTT is Benign according to our data. Variant chr11-77157263-G-GTGCCCACATTTT is described in ClinVar as Benign. ClinVar VariationId is 43342.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0571 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYO7ANM_000260.4 linkc.736-15_736-4dupTGCCCACATTTT splice_region_variant, intron_variant Intron 7 of 48 ENST00000409709.9 NP_000251.3 Q13402-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYO7AENST00000409709.9 linkc.736-16_736-15insTGCCCACATTTT intron_variant Intron 7 of 48 1 NM_000260.4 ENSP00000386331.3 Q13402-1
MYO7AENST00000458637.6 linkc.736-16_736-15insTGCCCACATTTT intron_variant Intron 7 of 48 1 ENSP00000392185.2 Q13402-2
MYO7AENST00000409619.6 linkc.703-16_703-15insTGCCCACATTTT intron_variant Intron 8 of 49 1 ENSP00000386635.2 Q13402-8

Frequencies

GnomAD3 genomes
AF:
0.0176
AC:
2674
AN:
152204
Hom.:
79
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0588
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00766
Gnomad ASJ
AF:
0.0176
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.000426
Gnomad OTH
AF:
0.0120
GnomAD2 exomes
AF:
0.00431
AC:
973
AN:
225834
AF XY:
0.00321
show subpopulations
Gnomad AFR exome
AF:
0.0508
Gnomad AMR exome
AF:
0.00335
Gnomad ASJ exome
AF:
0.0154
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000522
Gnomad OTH exome
AF:
0.00334
GnomAD4 exome
AF:
0.00218
AC:
3139
AN:
1439660
Hom.:
58
Cov.:
29
AF XY:
0.00188
AC XY:
1345
AN XY:
715366
show subpopulations
African (AFR)
AF:
0.0588
AC:
1919
AN:
32620
American (AMR)
AF:
0.00409
AC:
172
AN:
42094
Ashkenazi Jewish (ASJ)
AF:
0.0145
AC:
375
AN:
25860
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39094
South Asian (SAS)
AF:
0.000131
AC:
11
AN:
83810
European-Finnish (FIN)
AF:
0.0000190
AC:
1
AN:
52556
Middle Eastern (MID)
AF:
0.00349
AC:
20
AN:
5738
European-Non Finnish (NFE)
AF:
0.000277
AC:
304
AN:
1098204
Other (OTH)
AF:
0.00565
AC:
337
AN:
59684
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
149
298
447
596
745
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
66
132
198
264
330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0177
AC:
2690
AN:
152322
Hom.:
79
Cov.:
33
AF XY:
0.0173
AC XY:
1287
AN XY:
74488
show subpopulations
African (AFR)
AF:
0.0590
AC:
2454
AN:
41560
American (AMR)
AF:
0.00765
AC:
117
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.0176
AC:
61
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.000426
AC:
29
AN:
68032
Other (OTH)
AF:
0.0118
AC:
25
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
128
256
385
513
641
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0120
Hom.:
7
Asia WGS
AF:
0.00577
AC:
20
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 08, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 26, 2015
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Jul 30, 2015
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

c.736-15_736-4dup in intron 7 of MYO7A: This variant is not expected to have cli nical significance because it has been identified in 6.9% (343/4990) of African chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitut e.org; dbSNP rs111537161). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.2
Mutation Taster
=100/0
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs111033503; hg19: chr11-76868309; API